Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.
about
Tuberculosis and trimethoprim-sulfamethoxazoleHIV and tuberculosis--science and implementation to turn the tide and reduce deathsAssessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic reviewPersistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challengeSuccessful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South AfricaNational policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and LinksLow HIV testing rates among tuberculosis patients in Kampala, UgandaRisk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy.Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of deathImplementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-BissauWater filter provision and home-based filter reinforcement reduce diarrhea in Kenyan HIV-infected adults and their household members.Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South AfricaIncidence of orphanhood before and after implementation of a HIV care programme in Rakai, Uganda: Alpha Network HIV SupplementTrimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.Epidemiology of HIV-associated tuberculosis.A randomized trial of prolonged co-trimoxazole in HIV-infected children in AfricaDoes trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review.Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV/AIDS in Boru Meda Hospital.Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study.Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational researchThe complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South AfricaHIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria.Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis.Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.Trimethoprim Use prior to Pregnancy and the Risk of Congenital Malformation: A Register-Based Nationwide Cohort Study.The development of health policy in Malawi: the influence of context, evidence and links in the creation of a national policy for cotrimoxazole prophylaxisThe effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settingsReducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected womenPrimary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis.Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.HIV screening among TB patients and co-trimoxazole preventive therapy for TB/HIV patients in Addis Ababa: facility based descriptive studyTuberculosis and HIV co-infection: screening and treatment strategies.
P2860
Q24645397-D7F80812-D377-46FB-8CC6-8D398A45A319Q26824501-336C03D1-723A-4C60-AB0F-A270049FD3BFQ28084544-B3BE0512-6B92-492C-BA1F-282E7FDD75C0Q28088557-61B80403-0B4A-4A7C-9E2C-9EB13F1EB125Q28547344-6FC17B34-23CA-4DA7-867A-23C944919816Q30501533-DB10CF52-538D-4E32-B98E-C7AB3A69E6BDQ33548091-78DD042A-0EB9-4D3A-80A1-4A4955480C9FQ33584240-7E02CF1D-1B2B-431A-9CEB-2ED58897C489Q33622785-6CF54816-E8E5-4FB2-81D6-5DFBA3D4730AQ33743747-F7123682-AC5D-42DA-B46F-19CD567C7407Q33793347-3B8A04CD-A9EA-4DF4-BEF3-F7D0F56294D4Q33834841-B53EB80A-1798-491E-977A-BD5D08268199Q34015894-774467CC-AFF8-4376-A21B-70E82A4BACDBQ34209707-16C5F172-B73F-48EC-9CE2-57BCCF362C4FQ34213754-8735B488-DFF5-447E-A2D8-0A68628752B0Q34301812-4E424A9F-465F-4630-BD7D-83BB19A36B79Q34455442-D6A23089-7B98-42BC-AB70-E00C678411ABQ34519940-A8D2C238-20E1-4F90-ABAE-5F4B2C9B84C6Q34687538-825750D1-71AC-4A15-B00C-9982034B5117Q34762420-C49BD934-8118-4DC6-ABB5-272DE1A1A5EFQ35089191-746F3F65-59F3-4D4E-8DF2-0DE541241878Q35095036-C3497A63-3AA4-4D94-AEAC-968D4F5C5E3BQ35114820-FDA534A3-20E0-47B6-9D20-3C92A1194A75Q35207311-510B5F7A-3E81-4B0A-9B2A-8243197C734DQ35357639-F362FD2F-22DE-4F8C-8B5C-1AD6E493DA54Q35665530-86571B80-0DFD-44DE-9EA3-DD3F89592349Q35785542-85B90298-9EC1-4081-B46D-909D267BBD07Q35826952-3395C414-42F5-47BF-A0A0-C911089DF376Q36106589-47255D41-9750-4CA2-818C-E73CD3165FBBQ36517673-258A0D90-F86D-4C81-A185-4B48E451701CQ36651303-D4F58901-CCFA-44A7-867A-675F656B0F15Q36657522-707D4A2C-5E02-4EB2-BD59-C58DC58DEA24Q36743875-344D0990-BFBF-47A9-865C-BB93F3CE35F1Q37168581-E0162EBC-7E49-48F2-9211-647528B9BDF9Q37285167-70293F71-3C73-47CE-B4D3-08CF5A226EF5Q37398249-01EB0EAF-4DA3-4334-B392-1EBD239983A8Q37407836-D452DD7B-B26D-4E65-B6D7-2B12A624D19CQ37452075-B5A16B31-2F6B-4676-9FDC-82CA361192FBQ37548424-D9B136B8-9E83-40D2-BEA2-0717ED04E374Q37895251-17DE8EAF-3847-4B19-9BDD-ABAA589301F3
P2860
Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of co-trimoxazole prophyl ...... is: randomised clinical trial.
@en
Role of co-trimoxazole prophyl ...... is: randomised clinical trial.
@nl
type
label
Role of co-trimoxazole prophyl ...... is: randomised clinical trial.
@en
Role of co-trimoxazole prophyl ...... is: randomised clinical trial.
@nl
prefLabel
Role of co-trimoxazole prophyl ...... is: randomised clinical trial.
@en
Role of co-trimoxazole prophyl ...... is: randomised clinical trial.
@nl
P2093
P2860
P356
P1433
P1476
Role of co-trimoxazole prophyl ...... is: randomised clinical trial.
@en
P2093
Alwyn Mwinga
Andrew J Nunn
Chifumbe Chintu
Janet H Darbyshire
UNZA-UCLMS Project LUCOT Collaboration
P2860
P356
10.1136/BMJ.A257
P407
P577
2008-07-10T00:00:00Z